AI Insight
The American Association for Cancer Research has published its 16th annual Cancer Progress Report, presenting updated statistics on cancer incidence, mortality rates, and patient survivorship. The report documents how federally-funded cancer research across basic science, translational studies, clinical trials, and population health is leading to measurable improvements in patient outcomes and survival rates.
Why it matters
This annual report serves as a key benchmark for tracking progress in cancer treatment and prevention, demonstrating the tangible returns on federal research investments through agencies like NIH, NCI, FDA, and CDC. The findings provide evidence-based justification for continued public funding of cancer research and help identify areas requiring additional focus.
Understand the Science
The American Association for Cancer Research (AACR) has released the 16th edition of its annual Cancer Progress Report. This comprehensive report provides current data on cancer incidence, mortality and survivorship. It also outlines how basic, translational and clinical cancer research and cancer-related population science—largely supported by federal investments in the National Institutes of Health (NIH), the National Cancer Institute (NCI), the U.S. Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC)—are improving health and saving lives.
Source: AACR's annual cancer progress report highlights promising advances for patients